Pharmaceutical

Biogen and City Therapeutics to develop RNAi therapy

Biogen and City Therapeutics are set to partner for the development of new RNA interference (RNAi) therapies.

May 28, 2025 - 06:00
Biogen and City Therapeutics to develop RNAi therapy
Biogen and City Therapeutics are set to partner for the development of new RNA interference (RNAi) therapies.
Read the original article

Tags:

Previous Article

Patients and Staff Highlight Opportunities for Artificial Intelligence to Enhanc...

Next Article

How the cell and gene therapy market is taking shape

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ipsen’s Iqirvo wins European approval for primary biliary cholangitis

Ipsen’s Iqirvo wins European approval for primary bilia...

Sep 24, 2024

STAT+: Protesters slam health insurance lobby for Medicare Advantage coverage restrictions

STAT+: Protesters slam health insurance lobby for Medic...

Jun 28, 2023

Dianne Feinstein’s struggle with shingles reflects the long increase in cases

Dianne Feinstein’s struggle with shingles reflects the ...

Sep 30, 2023